Healthcare Pharmaceutical Biotech

Aetna Better Health(R) of West Virginia Opens New Community Resource Center in Clarksburg

May 29, 2026 9:00 AM

Originally published on CVS Health Company Newsroom Aetna Better Health® of West Virginia, a CVS Health® company (NYSE:CVS), announced the opening of a new Community Resource Center (CRC) located within the Community Care of West Virginia's Clarksburg facility. Open to the public, the center provides access to supportive health-related resources and a welcoming space for community meetings. The CRC plans to host wellness events and vaccine...

Read more

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

May 29, 2026 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,624,066 B2, titled "Compounds and Methods for Treatment of Coronavirus Infection." The newly granted patent protects Sunshine Biopharma's proprietary therapeutic compounds designed to inhibit...

Read more

MMJ International Holdings Files Formal Challenge To DEA Marijuana Rescheduling As Constitutional, Treaty, And Pharmaceutical Questions Collide

May 29, 2026 6:00 AM

MMJ International Holdings, ("MMJ"), together with its subsidiaries MMJ BioPharma Cultivation, and MMJ BioPharma Labs, announced today that it has formally entered the Drug Enforcement Administration's June 29, 2026 marijuana rescheduling hearing with a sweeping legal challenge raising constitutional, treaty, statutory, and pharmaceutical-regulatory objections to the federal government's proposed transfer of marijuana from Schedule I to Schedule...

Read more

Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term

May 29, 2026 4:50 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), a clinical-stage biopharmaceutical group focused on developing treatments for cancers and viral diseases, announces the grant of share options and a variation to the exercise period for certain investor warrants. Grant of Share Options The Board of Directors has agreed to grant options over a total of 1,200,000 ordinary shares of 1p each in the capital of the Company ("Board Share Options") to the...

Read more

ClinicsSpots Highlights Best-Rated Online Medical Assistant Programs for 2026

May 29, 2026 12:10 AM

For 2026, the best-rated online medical assistant programs are the ones that combine flexible coursework with clear certification preparation, verified clinical practice opportunities, transparent costs, student support, and curriculum coverage of both clinical and administrative skills. ClinicsSpots and many other top platforms consider Medical Prep fits into this discussion as an educational resource that helps learners understand medical...

Read more

Hone Health Review 2026: Pricing, Subscription Fine Print, and What to Confirm Before You Pay

May 28, 2026 9:35 PM

Disclosure: This article is a sponsored advertorial and contains affiliate links. A commission may be earned if you purchase through links in this article, at no additional cost to you. This content is for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment recommendations. Prescription treatment, if appropriate, is determined only by a licensed provider after independent review of lab work,...

Read more

Sunlight GLP-1 2026: Compounded Semaglutide From $159, What FDA's June 2026 Decision Means for Compounded GLP-1 Buyers, and 9 Things to Verify Before You Enroll

May 28, 2026 6:40 PM

Disclosure: This article contains affiliate links. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence editorial content or the evaluation of products or services. Disclosure is provided in accordance with FTC 16 CFR Part 255. This content is promotional in nature and is intended for consumer education regarding a commercially...

Read more

Super Strut Review 2026: Strut Health's 4-in-1 Dissolvable ED Tablet - Compounded Ingredients, Pricing, and the 7 Questions Every Patient Should Ask Before Consulting

May 28, 2026 3:50 PM

Disclosure: This article contains affiliate links. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence editorial content or the evaluation of products. Disclosure is provided in accordance with FTC 16 CFR Part 255. This content is promotional in nature and is intended for consumer education regarding a commercially available product....

Read more

Cantargia AB to Host Webcast Covering Rights Issue, Loan Agreement, and Strategic Priorities

May 28, 2026 3:35 PM

Cantargia (STO:CANTA) - With reference to the Company's press release on May 28, 2026, regarding the decision to conduct a rights issue in combination with a loan, Cantargia AB (Publ) ("Cantargia" or the "Company") invites shareholders, analysts and the press to a live web cast on June 1, 2026, at 4 pm CEST with details below. "This rights issue strengthens our ability to deliver on nadunolimab's full potential," said Hilde Steineger, CEO of...

Read more

Best Testosterone Replacement Therapy Online with KEEPS: Beware of TRT Testosterone Safety Information First

May 28, 2026 2:45 PM

The FDA Changed Testosterone Labeling in February 2025. Telehealth Prescribing Rules Are Being Finalized. Here's What Every Man Searching for Online TRT Needs to Verify Before He Pays $49. Title Clarification: The phrase "Best Testosterone Replacement Therapy Online" is included for search and advertorial continuity because readers may encounter similar category language in online TRT advertising. This article does not independently rank Keeps...

Read more

GATLAN Health Review 2026: Telehealth Pricing, TRT Access, Compounded GLP-1, and Patient Questions

May 28, 2026 1:55 PM

Advertorial Disclosure: This content is a paid advertorial for consumer education and contains affiliate links. A commission may be earned from qualifying actions taken through links in this article, at no additional cost to the reader. This content is not medical advice, does not replace consultation with a licensed healthcare professional, and does not guarantee eligibility for any prescription treatment. Prescription medications require...

Read more

The Naderi Center for Plastic Surgery Weighs In on What the Public Gets Wrong About Deep Plane Facelift Techniques and Longevity

May 28, 2026 1:00 PM

In response to widespread online speculation surrounding celebrities and facelift procedures, Dr. Shervin Naderi, a double board-certified specialist in facial plastic surgery at The Naderi Center for Plastic Surgery, is providing his professional insight into what truly matters when performing a facelift procedure. As discussions about facelifts surge across social media platforms, many surgeons and commentators have debated the techniques,...

Read more

Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion

May 28, 2026 11:00 AM

Cercare Medical, a leader in advanced neuroimaging software, today announced FDA 510(k) clearance (K253831) for its Cone-Beam CT (CBCT) Perfusion solution, enabling qualitative perfusion assessment directly from cone-beam CT data acquired during neurointerventional procedures. The clearance marks an important step forward in acute stroke imaging by bringing advanced perfusion analysis directly into the angio suite, allowing clinicians to assess...

Read more

MilliporeSigma's Approach to Embedding Sustainability Earlier in Product Development

May 28, 2026 11:00 AM

For MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, sustainability isn't treated as a standalone initiative. It's increasingly embedded across the product life cycle, from early R&D decisions to sourcing, manufacturing, packaging, distribution, customer use, and end of life. The most meaningful opportunities to reduce environmental impact happen when product teams are still making foundational design...

Read more

Two Sides of the "Gift of Life" From DaVita Teammates

May 28, 2026 11:00 AM

Experiencing kidney disease can change one's entire perspective on life, and for some it can spark a mission to help others navigate that same journey. As we reflect on the impact of organ donation, DaVita honors teammates who have experienced the transplant process from two profoundly different yet connected sides: as a transplant recipient and as a living donor. Building on Personal Experience to Find a Fulfilling Career: Chris's Journey Chris...

Read more

SoCal Aesthetic Surgery Named "Best of 2026" by BusinessRate for Excellence in Plastic Surgery

May 28, 2026 10:00 AM

SoCal Aesthetic Surgery, a facial plastic surgery practice based in Irvine, California, has been named a "Best of 2026" award winner by BusinessRate. The recognition highlights the practice's strong reputation among patients and its consistently positive feedback across verified online review platforms. The award places SoCal Aesthetic Surgery among a select group of businesses recognized for maintaining high levels of customer satisfaction and...

Read more

Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders

May 28, 2026 10:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) and family company Napo Pharmaceuticals (Napo) today highlighted how the Company's long-standing research in ethnobotanical medicine, sustainable harvesting, and regulatory drug development under botanical guidance ("botanical drug") continues to inform the development of crofelemer as a novel oral adjunctive therapy to PS for rare congenital gastrointestinal intestinal failure (IF) disorders, including...

Read more

Will Physicians Risk Their Licenses For CMS Hemp Products The FDA Never Approved?

May 28, 2026 9:50 AM

Judge Trevor McFadden dismissed the challenge to CMS's Substance Access Beneficiary Engagement Incentive (BEI) program on standing grounds, ruling that no plaintiff had demonstrated a sufficiently concrete injury. But in doing so, the court may have unintentionally revealed something far more important: If the judiciary will not intervene yet, and CMS has chosen to move forward without FDA approval standards, then the burden of protecting...

Read more

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

May 28, 2026 9:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced a one for ten reverse split of its common stock, effective at market open on June 1, 2026. The reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The reverse stock split will reduce the Company's issued and...

Read more

Medical Care Technologies (OTC PINK:MDCE) Provides Additional Details Regarding MDCE Melanoma Scan Beta Imaging Platform

May 28, 2026 8:47 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on AI-powered imaging and wellness applications, today provided additional details regarding the design framework and development objectives of its MDCE Melanoma Scan Beta platform. The beta-stage platform is being developed as an AI-assisted imaging and body-map monitoring application intended to support image organization and long-term...

Read more